
GC62430
KA2507
Also known as 4-[[di(pyrazin-2-yl)amino]methyl]-N-hydroxybenzamide
KA2507 is a potent, orally active and selective HDAC6 inhibitor, with an IC50 of 2·5 nM· KA2507 shows antitumor activities and immune modulatory effects in preclinical models
ChemicalCAS1636894-46-6MW322.32FormulaC16H14N6O2
- CAS number
- 1636894-46-6
- Molecular weight
- 322.32
- Formula
- C16H14N6O2
- Solubility
- DMSO : 66·67 mg/mL (206·84 mM; Need ultrasonic)
- InChIKey
- LXHMTDHBMRZSHJ-UHFFFAOYSA-N
- Catalogue number
- GC62430
- Brand
- GLPBIO
Computed properties PubChem CID 117703516 · XLogP 0.3 · TPSA 104 Ų · H-bond donors 2
- XLogP
- 0.3
- TPSA
- 104 Ų
- H-bond donors
- 2
- H-bond acceptors
- 7
- Rotatable bonds
- 5
- Heavy atoms
- 24
SMILES C1=CC(=CC=C1CN(C2=NC=CN=C2)C3=NC=CN=C3)C(=O)NO
Computed descriptors from PubChem (CID 117703516), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il